Pages that link to "Q41486306"

The following pages link to Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. (Q41486306):

Displaying 28 items.

• Free radicals: properties, sources, targets, and their implication in various diseases (Q27000071) (← links)
• Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis (Q28394921) (← links)
• Multiple sclerosis: overview of disease-modifying agents (Q34342662) (← links)
• The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis (Q34413247) (← links)
• Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels (Q35016996) (← links)
• The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders (Q35246024) (← links)
• The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders (Q35256491) (← links)
• Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro (Q35582048) (← links)
• Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage (Q35598836) (← links)
• Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. (Q36376697) (← links)
• Redox processes in neurodegenerative disease involving reactive oxygen species (Q36460613) (← links)
• Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage (Q36486079) (← links)
• Uniform distributions of glucose oxidation and oxygen extraction in gray matter of normal human brain: No evidence of regional differences of aerobic glycolysis (Q36860655) (← links)
• Down-regulation of Myelin Gene Expression in Human Oligodendrocytes by Nitric Oxide: Implications for Demyelination in Multiple Sclerosis (Q37334625) (← links)
• Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis (Q37376574) (← links)
• Oxidative Stress and Neurobiology of Demyelination (Q38287176) (← links)
• Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption (Q39570654) (← links)
• A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells. (Q41450220) (← links)
• Broadening our focus in the search for cell transplantation-based glaucoma therapies (Q42909990) (← links)
• The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy. (Q43375909) (← links)
• Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis. (Q50945427) (← links)
• Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model. (Q55451223) (← links)
• Copper signalling: causes and consequences (Q57801718) (← links)
• Relevance of peroxynitrite formation and 3-nitrotyrosine on spermatozoa physiology (Q60173945) (← links)
• S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis (Q88473015) (← links)
• Relationship between thiol-disulphide homeostasis and visual evoked potentials in patients with multiple sclerosis (Q90101222) (← links)
• A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis (Q91713954) (← links)
• Impairment between Oxidant and Antioxidant Systems: Short- and Long-term Implications for Athletes' Health (Q92816731) (← links)